Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPremier Foods Regulatory News (PFD)

Share Price Information for Premier Foods (PFD)

Share Price is delayed by 15 minutes
Get Live Data
202.80    4.40 (2.22%)
Bid:
202.80
Ask:
203.00
Spread: 0.20 (0.099%)
Market Cap: £1.75b
PFD Live PriceLast checked at - London Stock Exchange

Intraday Premier Foods Share Chart

Directorate Change

14 Mar 2018 13:53

RNS Number : 7373H
Premier Foods plc
14 March 2018
 

 

 

Premier Foods plc ("Premier Foods" or the "Company")

14 March 2018

 

Board Retirement

 

Premier Foods announces that Tsunao Kijima, non-executive director, has advised the Company today that he intends to stand down as a director of Premier Foods on 23 March 2018, following his decision to retire from Nissin Foods Holdings Company Ltd ("Nissin"). Mr Kijima has served on the Board since July 2016 pursuant to the terms of the Relationship Agreement between the Company and Nissin.

 

Board Appointment

 

Following Mr Kijima's retirement, Shinji Honda will be appointed as a non-executive director and as Nissin's representative director pursuant to the Relationship Agreement, with effect from 23 March 2018.

 

Mr Honda is Chief Strategy Officer of Nissin, with responsibility for overseas operations, including Europe. Prior to joining Nissin in January 2018, Mr Honda spent his entire professional career at Takeda Pharmaceutical Company Limited ("Takeda"), a leading Japanese pharmaceutical company. He was named Member of the Board of Takeda in June 2013 and Corporate Strategy Officer in October 2014, having previously spent a significant amount of time overseeing Takeda's international operations where his responsibilities included President and CEO of Takeda North America.

 

Commenting on the changes Keith Hamill, Chairman of Premier Foods, said "I would like to take this opportunity to thank Mr Kijima for his significant contribution to both the Board and the partnership between Premier and Nissin, which has helped to ensure the successful launch of a number of exciting new products to market. We welcome Mr Honda to the Board and look forward to working with him in the future".

 

Mr Honda served as Member of the Board of Takeda Pharmaceutical Company Limited (listed on the first section of the Tokyo Stock Exchange) from June 2013 until June 2017. No further information is required to be disclosed pursuant to LR 9.6.13 R.

For further information please contact:

Andrew McDonald, General Counsel & Company Secretary +44 (0) 1727 815 850

Hannah Collyer, Corporate Affairs Director +44 (0) 1727 815 850

Richard Godden, Director of Investor Relations +44 (0) 1727 815 850

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
BOAXZLFFVXFEBBF
Date   Source Headline
2nd Jun 202611:11 amRNSNotice of AGM
1st Jun 20262:46 pmRNSDirector/PDMR Shareholding
22nd May 20263:00 pmRNSDirector/PDMR Shareholding
14th May 20267:00 amRNSFull-year Results
1st Apr 20269:45 amRNSTotal Voting Rights
3rd Feb 202610:52 amRNSDirector/PDMR Shareholding
2nd Feb 202611:30 amRNSDirector/PDMR Shareholding
28th Jan 202612:00 pmRNSDirector/PDMR Shareholding
27th Jan 202610:30 amRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSQ3 Trading Update
16th Dec 20252:31 pmRNSDirector/PDMR Shareholding
4th Dec 20257:00 amRNSHolding(s) in Company
20th Nov 20252:11 pmRNSDirector/PDMR Shareholding
19th Nov 20252:21 pmRNSDirector/PDMR Shareholding
13th Nov 20257:00 amRNSHalf-year Results
1st Oct 202511:51 amRNSBlock listing Interim Review
1st Oct 202511:48 amRNSTotal Voting Rights
23rd Sep 202512:33 pmRNSDirector/PDMR Shareholding
18th Sep 20251:10 pmRNSDirector/PDMR Shareholding
9th Sep 20253:09 pmRNSDirector/PDMR Shareholding
21st Aug 20257:00 amRNSAcquisition of Merchant Gourmet
17th Jul 20254:29 pmRNSResult of AGM
17th Jul 20257:00 amRNSQuarter 1 Trading Update
9th Jun 20252:47 pmRNSDirector/PDMR Shareholding
3rd Jun 20259:07 amRNSNotice of AGM
2nd Jun 20253:37 pmRNSDirector/PDMR Shareholding
28th May 20251:25 pmRNSDirector/PDMR Shareholding
22nd May 20252:46 pmRNSDirector/PDMR Shareholding
16th May 202512:32 pmRNSHolding(s) in Company
15th May 20257:00 amRNSPreliminary Results
1st Apr 202510:00 amRNSBlock listing Interim Review
1st Apr 20259:00 amRNSTotal Voting Rights
17th Mar 20253:13 pmRNSDirector/PDMR Shareholding
13th Mar 20254:19 pmRNSDirector/PDMR Shareholding
13th Mar 202512:19 pmRNSDirector/PDMR Shareholding
5th Feb 20251:05 pmRNSDirector/PDMR Shareholding
4th Feb 202511:30 amRNSDirector/PDMR Shareholding
21st Jan 20257:00 amRNSQ3 Trading Update
17th Dec 20249:30 amRNSDirector/PDMR Shareholding
9th Dec 20243:59 pmRNSDirector/PDMR Shareholding
14th Nov 20247:00 amRNSHalf-Year Results
8th Nov 202411:56 amRNSChange to Board Committee Memberships
1st Oct 202410:00 amRNSBlock listing Interim Review
1st Oct 20249:00 amRNSTotal Voting Rights
19th Sep 20242:35 pmRNSHolding(s) in Company
13th Sep 20242:10 pmRNSDirector/PDMR Shareholding
6th Aug 20244:08 pmRNSDirector/PDMR Shareholding
1st Aug 20242:33 pmRNSDirector/PDMR Shareholding
18th Jul 20244:16 pmRNSChange to Board Committee Membership
18th Jul 20242:18 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.